eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
4/2020
vol. 45
 
Share:
Send email
Share:
abstract:
Review paper

The role of Lactobacillus plantarum 299v in supporting treatment of selected diseases

Karolina Kaźmierczak-Siedlecka
1
,
Agnieszka Daca
2
,
Marcin Folwarski
3
,
Jacek M. Witkowski
4
,
Ewa Bryl
2
,
Wojciech Makarewicz
1

  1. Department of Surgical Oncology, Medical University of Gdansk, Gdansk, Poland
  2. Department of Pathology and Experimental Rheumatology, Medical University of Gdansk, Gdansk, Poland
  3. Department of Clinical Nutrition and Dietetics, Medical University of Gdansk, Gdansk, Poland
  4. Department of Physiopathology, Medical University of Gdansk, Gdansk, Poland
Centr Eur J Immunol 2019; 45 (4): 488-493
DOI: https://doi.org/10.5114/ceji.2020.101515
Online publish date: 2021/01/25
View full text Get citation
 
PlumX metrics:
Alterations in composition of human gut microbiome can lead to its dysbiosis. It is associated with gastrointestinal side effects during anti-cancer treatment, antibiotics administration, or infectious agents. There are studies confirming positive effect of consuming Lactobacillus plantarum 299v on intestinal microflora. This review summarizes the current knowledge about the role of L. plantarum 299v in supporting treatment of selected diseases, such as cancer, irritable bowel syndrome (IBS), and Clostridium difficile infection. The immunomodulating properties of L. plantarum 299v include an increase in the level of anti-inflammatory cytokines, which reduce the risk of cancer and improve the efficacy of regimens. The intake of L. plantarum 299v provides benefits for IBS patients, mainly due to normalization of stool and relief of abdominal pain, which significantly improves the quality of life of IBS patients. In addition, the intake of L. plantarum 299v prevents C. difficile-associated diarrhea among patients receiving antibiotic treatment. Due to the limited possibilities of treating these diseases and numerous complications of cancer treatment, there is a need for new therapeutic strategies. The administration of L. plantarum 299v seems to be useful in these cases.
keywords:

Lactobacillus plantarum 299v, cancer, Clostridium difficile infection, irritable bowel syndrome, diarrhea
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.